The WHO estimates the average medication adherence rate is 50% in developed nations, though the U.S. trails other countries in reported adherence on Medisafe.…

Johnson & Johnson

AZ caps busy week of hiveoffs with $330M Rhinocort sale to J&J's Cilag

Sun noses ahead of J&J in race for IL-23 finish line, but other rivals lie in wait

J&J's next-gen psoriasis med tops Humira in head-to-head showdown

Johnson & Johnson hid faulty device concerns during key Xarelto study: BMJ

Do ADHD meds really help kids finish homework? Maybe not, study says

As hep C proves a 'flash in the pan' once again, Gilead's sales will 'erode massively': Analyst

J&J's Stelara, squeezed in psoriasis, grabs new market with Crohn's approval

J&J pushes to move talcum powder cancer lawsuits to NJ, where it's won two

Roche to beat Novartis, Pfizer to pharma throne by 2022 as industry passes $1T mark

With Biogen launch, the U.K. has two anti-TNF biosims. In the U.S.? Not soon, analyst says